Seal Biosciences
Company

Seal Biosciences

Biotechnology Research San Francisco, California, United States 6 employees
Employees
6

Seal Biosciences Overview

Headquarters
San Francisco, California, United States
Industry
Biotechnology Research
Employees
6
Founded
2016
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Seal Biosciences

We are developing diagnostic assays to identify patients who are most likely to respond to targeted cancer therapies. Our first assay for RasGRP1, has been clinically validated as a predictive and prognostic marker for response to anti-EGFR therapy in metastatic colorectal cancer. We are currently exploring other indications where inhibition of the EGFR pathway is a central therapeutic modality, and uncovering more about the role of RasGRP1 in regulation of this key signaling pathway.

Compare Similar Companies to Seal Biosciences